EconPapers    
Economics at your fingertips  
 

High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes

Zachary R. Popkin-Hall (), Karamoko Niaré, Rebecca Crudale, Alfred Simkin, Abebe A. Fola, Juan F. Sanchez, Danielle L. Pannebaker, David J. Giesbrecht, Isaac E. Kim, Özkan Aydemir, Jeffrey A. Bailey, Hugo O. Valdivia and Jonathan J. Juliano
Additional contact information
Zachary R. Popkin-Hall: University of North Carolina
Karamoko Niaré: Brown University
Rebecca Crudale: Brown University
Alfred Simkin: Brown University
Abebe A. Fola: Brown University
Juan F. Sanchez: U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH)
Danielle L. Pannebaker: U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH)
David J. Giesbrecht: Brown University
Isaac E. Kim: The Warren Alpert Medical School of Brown University
Özkan Aydemir: UMass Chan Medical School
Jeffrey A. Bailey: Brown University
Hugo O. Valdivia: U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH)
Jonathan J. Juliano: University of North Carolina

Nature Communications, 2024, vol. 15, issue 1, 1-11

Abstract: Abstract Plasmodium vivax transmission occurs throughout the tropics and is an emerging threat in areas of Plasmodium falciparum decline, causing relapse infections that complicate treatment and control. Targeted sequencing for P. falciparum has been widely deployed to detect population structure and the geographic spread of antimalarial and diagnostic resistance. However, there are fewer such tools for P. vivax. Leveraging global variation data, we designed four molecular inversion probe (MIP) genotyping panels targeting geographically differentiating SNPs, neutral SNPs, putative antimalarial resistance genes, and vaccine candidate genes. We deployed these MIP panels on 866 infections from the Peruvian Amazon and identified transmission networks with clonality (IBD[identity by descent]>0.99), copy number variation in Pvdbp and multiple Pvrbps, mutations in antimalarial resistance orthologs, and balancing selection in 13 vaccine candidate genes. Our MIP panels are the broadest genotyping panel currently available and are poised for successful deployment in other regions of P. vivax transmission.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-54731-y Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-54731-y

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-54731-y

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-54731-y